B
Braidwell Portfolio holdings
AUM
$3.13B
1-Year Est. Return
31.52%
This Fund
S&P 500
1 Year Est. Return
+31.52%
AUM
$3.13B
AUM Growth
-$243M
(-7.2%)
Holding
93
Top Buys
| 1 | +$55.4M | |
| 2 | +$42.4M | |
| 3 | +$40.1M | |
| 4 |
Celldex Therapeutics
CLDX
|
+$33.4M |
| 5 |
Illumina
ILMN
|
+$31.7M |
Top Sells
| 1 | +$74.8M | |
| 2 | +$67M | |
| 3 | +$58.5M | |
| 4 |
Apogee Therapeutics
APGE
|
+$54.4M |
| 5 |
Danaher
DHR
|
+$42M |
Sector Composition
| 1 | Healthcare | 83.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vera Therapeutics
VERA
$2.87B
| $39.7M | 1.27% |
784,742
+312,003
|
|
||
27
iRhythm Holdings
IRTC
$4.15B
| $38.6M | 1.23% |
217,345
-8,500
|
|
||
28
Transmedics
TMDX
$5.02B
| $38.4M | 1.23% |
315,341
-35,907
|
|
||
29
BioMarin Pharmaceuticals
BMRN
$11.5B
| $35.7M | 1.14% |
601,520
+73,520
|
|
||
|
30
Illumina
ILMN
$20.3B
| $35.4M | 1.13% |
+269,673
|
|
||
31
Kymera Therapeutics
KYMR
$7.21B
| $35.3M | 1.13% |
454,259
+177,567
|
|
||
32
Fulcrum Therapeutics
FULC
$520M
| $34.6M | 1.11% |
3,061,222
+2,841,734
|
|
||
33
Penumbra
PEN
$13.4B
| $34.2M | 1.1% |
110,152
-31,376
|
|
||
|
MBX
34
MBX Biosciences
MBX
$1.48B
| $32.1M | 1.03% |
+1,018,600
|
|
||
35
RAPT Therapeutics
RAPT
$1.68B
| $31.5M | 1.01% |
+929,694
|
|
||
36
CareDx
CDNA
$964M
| $29.9M | 0.96% |
1,585,220
-597,561
|
|
||
37
Dyne Therapeutics
DYN
$2.66B
| $28.9M | 0.92% |
1,478,329
-1,252,152
|
|
||
38
enGene Holdings
ENGN
$670M
| $28.3M | 0.9% |
3,131,319
+865,000
|
|
||
39
Legend Biotech
LEGN
$3.41B
| $28.2M | 0.9% |
1,298,142
-528,013
|
|
||
40
Maravai LifeSciences
MRVI
$524M
| $27.1M | 0.87% |
8,353,287
|
|
||
|
41
Danaher
DHR
$146B
| $27.1M | 0.87% |
118,227
-191,112
|
|
||
42
argenx
ARGX
$46.8B
| $26.1M | 0.83% |
31,007
-45,084
|
|
||
43
Natera
NTRA
$27.9B
| $25.5M | 0.82% |
+111,500
|
|
||
|
DRUG
44
Bright Minds Biosciences
DRUG
$810M
| $25.3M | 0.81% |
324,358
+20,673
|
|
||
45
Terns Pharmaceuticals
TERN
$4.57B
| $23.2M | 0.74% |
+575,321
|
|
||
46
Evolus
EOLS
$278M
| $20.6M | 0.66% |
+3,105,209
|
|
||
47
Biogen
BIIB
$27.6B
| $20.4M | 0.65% |
+115,700
|
|
||
48
OrthoPediatrics
KIDS
$482M
| $19.5M | 0.63% |
1,100,370
-7,400
|
|
||
|
TECX
49
Tectonic Therapeutic
TECX
$430M
| $19.3M | 0.62% |
927,524
+190,657
|
|
||
50
Ventyx Biosciences
VTYX
$1B
| $17.3M | 0.55% |
+1,920,255
|
|